Celcuity Inc. (NASDAQ: CELC) has surged +76% over the past month as investors pile into next-generation oncology names with high-upside clinical pipelines. The company is focused on developing targeted cancer therapies that precisely disrupt key cellular signaling pathways, positioning Celcuity at the forefront of precision medicine for hard-to-treat tumors.

Momentum has accelerated on growing optimism around Celcuity’s lead drug candidates, improving clinical trial readouts, and a strengthening balance sheet that supports continued development. With rising interest from institutional investors, expanding oncology partnerships, and a clear focus on high-value indications, CELC is quickly emerging as one of the most powerful momentum plays in the biotech sector right now.

1 Month Performance:

Click here to see the chart

Lumentum Holdings Inc. (NASDAQ: LITE) has surged +51% over the past month as investors rotate into optical and photonics names leveraged to the boom in AI data centers and high-speed networking. The company supplies critical laser and optical components used in cloud infrastructure, 5G networks, and next-gen AI hardware, making Lumentum a key enabler of the world’s escalating demand for high-bandwidth connectivity.

Momentum accelerated after renewed optimism around AI-driven demand for high-speed optical links and expectations of a rebound in telecom and datacom spending. With a strong position in 400G/800G data center optics, growing exposure to AI infrastructure, and operating leverage as volumes recover, LITE is emerging as one of the strongest momentum names in the photonics and networking space right now.

1 Month Performance:

Click here to see the chart

Appian Corporation (NASDAQ: APPN) has rocketed +49% over the past month as investors flock to enterprise AI and automation plays. The company is building a unified low-code automation platform that lets organizations design, deploy, and scale complex workflows and applications with minimal code — helping large enterprises modernize legacy systems, cut costs, and move faster.

Momentum has accelerated on growing excitement around Appian’s AI-assisted app building, stronger customer adoption, and an expanding ecosystem of enterprise use cases across finance, government, and healthcare. With its platform increasingly positioned as the “operating layer” for digital transformation, APPN is emerging as one of the strongest momentum names in the workflow automation and low-code software space right now.

1 Month Performance:

Click here to see the chart

Guardant Health Inc. (NASDAQ: GH) has surged +47% over the past month as investors flock to precision oncology stocks showing renewed momentum. The company is a leader in liquid biopsy technology, developing blood-based tests that detect and monitor cancer with far less invasiveness than traditional methods — a breakthrough approach that is rapidly gaining adoption across the medical community.

Momentum accelerated after stronger-than-expected test volume growth and rising confidence in Guardant’s expanding clinical pipeline, including early detection and minimal residual disease (MRD) applications. With the shift toward personalized cancer care accelerating and Guardant positioned as a top innovator in the space, GH is emerging as one of the strongest momentum names in the next-generation cancer diagnostics sector right now.

1 Month Performance:

Click here to see the chart

Globalstar Inc. (NYSE American: GSAT) has climbed +37% over the past month as investors pile into satellite connectivity and direct-to-device plays. The company operates a global low-Earth orbit satellite network designed to deliver mobile voice, data, and IoT services far beyond the reach of traditional cellular towers, positioning GSAT at the center of the push for always-on, global coverage.

Momentum has accelerated on growing excitement around direct smartphone connectivity, expanded spectrum partnerships, and progress toward next-generation 5G non-terrestrial networks (NTN). With commercial deployments advancing and a strengthening roster of enterprise and device partners, GSAT is emerging as one of the strongest momentum names in the mobile satellite services space right now.

1 Month Performance:

Click here to see the chart

We send stocks like this all the time inside our Crown Elite Research Service.

You get access to real trade setups before they move with —

Sign up before November 24 and you’ll also get my Top 5 Elite Stocks for November 2025 list.

After the 24th, the bonus is gone.

Talk soon,

— Jordan

👑 Crown Trading